Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
PT Jayamas Medica Industri Tbk specializes in the manufacturing and distribution of medical instruments and supplies, primarily serving the Indonesian healthcare market. The company benefits from a robust distribution network and strong relationships with hospitals and clinics, which enhances its competitive position in a growing sector.
The company generates revenue through the sale of a diverse range of medical instruments and supplies, leveraging its established distribution channels and strong brand recognition in Indonesia. Its competitive advantages include a low debt-to-equity ratio of 0.09, allowing for flexible financing options, and a current ratio of 11.08, indicating strong liquidity.
Changes in healthcare spending in Indonesia
Regulatory changes impacting medical supply approvals
Technological advancements in medical devices
Market share shifts among competitors
Regulatory changes affecting product approvals
Technological disruption in medical devices
Emerging local competitors with lower pricing
Global players entering the Indonesian market
Low debt levels provide stability but limit aggressive expansion
Potential liquidity risks if cash flow declines
moderate - The company's performance is linked to healthcare spending, which can be influenced by GDP growth and consumer spending patterns.
Interest rates affect the company's financing costs for expansion and capital expenditures, potentially impacting profit margins and valuation multiples.
minimal
growth - The company is positioned for growth in a rapidly expanding healthcare market.
low - The stock has shown relatively stable performance with a beta less than 1.
